Indian Journal of Gastroenterology

, Volume 37, Issue 1, pp 50–57 | Cite as

Alcohol-related acute-on-chronic liver failure—Comparison of various prognostic scores in predicting outcome

  • Ujjwal Sonika
  • Shekhar Jadaun
  • Gyan Ranjan
  • Gyanranjan Rout
  • Deepak Gunjan
  • Saurabh Kedia
  • Baibaswata Nayak
  • ShalimarEmail author
Original Article


Background and Aims

Various prognostic scores are available for predicting outcome in acute-on-chronic liver failure (ACLF). We compared the available prognostic models as predictors of outcome in alcohol-related ACLF patients.


All consecutive patients with alcohol-related ACLF were included. At admission, prognostic indices-acute physiology and chronic health evaluation score (APACHE II), model for end-stage liver disease (MELD), MELD-Na, Maddrey’s discriminant function (DF), age-bilirubin-INR-creatinine (ABIC), and Chronic Liver Failure Consortium (CLIF-C) ACLF score (CLIF-C ACLF) score were calculated. Receiver operator characteristic (ROC) curves were plotted for all prognostic scores with in-hospital, 90-day, and 1-year mortality as outcome.


Of the 171 patients, 170 were males, and grade 1 ACLF in 20 (11.7%), grade 2 in 52 (30.4%), and grade 3 in 99 (57.9%) patients. One hundred and nineteen (69.6%) died in-hospital. The median (IQR) Maddrey’s score, MELD, MELD-Na, ABIC, APACHE II, and CLIF-C ACLF were 87.8 (66.5–123.0), 33.1 (27.6–40.0), 34.4 (29.5–40.0), 8.5 (7.3–9.6), 15 (12–21), and 51.1 (44.1–56.4), respectively. On multivariate Cox regression analysis, independent predictors of in-hospital outcome were presence of hepatic encephalopathy (early HR, 2.078; 95%CI, 1.173–3.682, p = 0.012 and advanced, HR, 2.330; 95% CI, 1.270–4.276, p = 0.006), elevated serum creatinine (HR, 1.140; 95% CI, 1.023–1.270, p = 0.018), and infection at admission (HR, 1.874; 95% CI, 1.160–23.029, p = 0.010). On comparison of ROC curves, APACHE II and CLIF-C ACLF AUROC were significantly higher than MELD, MELD-Na, DF, and ABIC (p < 0.05) for predicting in-hospital, 90-day, and 1-year mortality. The AUROC was highest for APACHE II followed by CLIF-C ACLF (Hanley and McNeil, p = 0.660).


Alcohol-related ACLF has high in-hospital mortality. Among the available prognostic scores, CLIF-C ACLF and APACHE II perform best.


Acute-on-chronic liver failure Mortality APACHE II score CLIF-C ACLF score Prognostic score 


Author contributions

Ujjwal Sonika: acquisition of data, data analysis, interpretation of data, and drafting of manuscript.

Shekhar Jadaun: acquisition of data and drafting of manuscript.

Gyan Ranjan: acquisition of data and drafting of manuscript.

Gyanranjan Rout: acquisition of data and drafting of manuscript.

Deepak Gunjan: acquisition of data and drafting of manuscript.

Saurabh Kedia: acquisition of data and drafting of manuscript.

Baibaswata Nayak: acquisition of data and drafting of manuscript.

Shalimar: study design and concept, interpretation of data, and critical revision of manuscript for important intellectual content

Compliance with ethical standards

Funding information


Transcript profiling


Conflict of interest

US, SJ, GR, GR, DG, SK, BN, and S declare that they have no conflict of interest.

Ethics statement

The authors declare that the study was performed in a manner to conform to the Helsinki Declaration of 1975, as revised in 2000 and 2008, concerning human and animal rights. The protocol was approved by the Institutional Ethics Committee and informed consent was obtained from the study subjects.


  1. 1.
    Jalan R, Yurdaydin C, Bajaj JS, et al. Toward an improved definition of acute-on-chronic liver failure. Gastroenterology. 2014;147:4–10.CrossRefPubMedGoogle Scholar
  2. 2.
    Jalan R, Gines P, Olson JC, et al. Acute-on-chronic liver failure. J Hepatol. 2012;57:1336–48.CrossRefPubMedGoogle Scholar
  3. 3.
    Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144:1426–37. 1437.e1–9CrossRefPubMedGoogle Scholar
  4. 4.
    Shalimar, Kumar D, Vadiraja PK, et al. Acute on chronic liver failure because of acute hepatic insults: etiologies, course, extrahepatic organ failure and predictors of mortality. J Gastroenterol Hepatol. 2016;31:856-64.Google Scholar
  5. 5.
    Bajaj JS, O’Leary JG, Reddy KR, et al. Second infections independently increase mortality in hospitalized patients with cirrhosis: the north American consortium for the study of end-stage liver disease (NACSELD) experience. Hepatology. 2012;56:2328–35.Google Scholar
  6. 6.
    Duan BW, Lu SC, Wang ML, et al. Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases. J Surg Res. 2013;183:936–43.Google Scholar
  7. 7.
    Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–29.Google Scholar
  8. 8.
    Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–9.Google Scholar
  9. 9.
    Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864–71.Google Scholar
  10. 10.
    Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130:1652–60.Google Scholar
  11. 11.
    Maddrey WC, Boitnott JK, Bedine MS, Weber FL, Mezey E, White RI. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology. 1978;75:193–9.PubMedGoogle Scholar
  12. 12.
    Dominguez M, Rincón D, Abraldes JG, et al. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am J Gastroenterol. 2008;103:2747–56.CrossRefPubMedGoogle Scholar
  13. 13.
    Jalan R, Saliba F, Pavesi M, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol. 2014;61:1038–47.CrossRefPubMedGoogle Scholar
  14. 14.
    Shalimar, Kedia S, Gunjan D, et al. Acute liver failure due to hepatitis E virus infection is associated with better survival than other etiologies in Indian patients. Dig Dis Sci. 2017;62:1058-66.Google Scholar
  15. 15.
    Riegler JL, Lake JR. Fulminant hepatic failure. Med Clin North Am. 1993;77:1057–83.Google Scholar
  16. 16.
    Shalimar, Kedia S, Mahapatra SJ, et al. Severity and outcome of acute-on-chronic liver failure is dependent on the etiology of acute hepatic insults: analysis of 368 patients. J Clin Gastroenterol. 2017;51:734-41.Google Scholar
  17. 17.
    Fernández J, Acevedo J, Weist R, et al. Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis. Gut. 2017;pii: gutjnl-2017-314240.Google Scholar
  18. 18.
    Jameel S, Durgapal H, Habibullah CM, Khuroo MS, Panda SK. Enteric non-A, non-B hepatitis: epidemics, animal transmission, and hepatitis E virus detection by the polymerase chain reaction. J Med Virol. 1992;37:263–70.Google Scholar
  19. 19.
    Nanda SK, Yalcinkaya K, Panigrahi AK, Acharya SK, Jameel S, Panda SK. Etiological role of hepatitis E virus in sporadic fulminant hepatitis. J Med Virol. 1994;42:133–7.Google Scholar
  20. 20.
    Bhatia V, Singh R, Acharya SK. Predictive value of arterial ammonia for complications and outcome in acute liver failure. Gut. 2006;55:98–104.Google Scholar
  21. 21.
    Shalimar, Saraswat V, Singh SP, et al. Acute-on-chronic liver failure in India: The Indian National Association for Study of the Liver consortium experience. J Gastroenterol Hepatol. 2016;31:1742–9.Google Scholar
  22. 22.
    Chu CM, Liaw YF. Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: a longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline. J Hepatol. 2005;43:411–7.Google Scholar
  23. 23.
    Buchel E, Van Steenbergen W, Nevens F, Fevery J. Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery. Am J Gastroenterol. 2002;97:3160–5.Google Scholar
  24. 24.
    European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53:397–417.CrossRefGoogle Scholar
  25. 25.
    Thursz MR, Richardson P, Allison M, et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med. 2015;372:1619–28.CrossRefPubMedGoogle Scholar
  26. 26.
    Mathurin P, Moreno C, Samuel D, et al. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med. 2011;365:1790–800.CrossRefPubMedGoogle Scholar
  27. 27.
    Duseja A, Choudhary NS, Gupta S, Dhiman RK, Chawla Y. APACHE II score is superior to SOFA, CTP and MELD in predicting the short-term mortality in patients with acute-on-chronic liver failure (ACLF). J Dig Dis. 2013;14:484–90.Google Scholar
  28. 28.
    Constantine K, Eric S, Juan R. Prognostic scores in acute on chronic liver failure patients admitted to ICU: a Canadian study [abstract]. Crit Care Med. 2015;43:94.Google Scholar

Copyright information

© Indian Society of Gastroenterology 2018

Authors and Affiliations

  1. 1.Department of Gastroenterology and Human NutritionAll India Institute of Medical SciencesNew DelhiIndia

Personalised recommendations